Systemic Corticosteroid
Pregnancy: Compatible — prednisolone used to treat IBD flares in pregnancy. Small risk of cleft palate in first trimester at high doses. Monitor fetal growth.
Prednisolone (IBD / GI Use)
Brand names: Deltacortril, Prednesol
Adult dose
Dose: UC / Crohn's acute flare: 40mg once daily for 4 weeks, then taper by 5mg/week. Autoimmune hepatitis: 30–40mg OD for 4 weeks, taper to maintenance 5–10mg OD.
Route: Oral (or IV hydrocortisone 400mg/day in severe UC)
Frequency: Once daily in the morning (mimics diurnal cortisol rhythm)
Max: 60mg/day
Acute severe UC (Truelove and Witts criteria): IV hydrocortisone 100mg QDS preferred — assess response at 72 hours (Oxford criteria). If no response at 72h: consider rescue therapy (infliximab or ciclosporin) or colectomy. Tapering: once remission achieved, reduce by 5mg/week. Do not stop abruptly if on >7.5mg/day for >3 weeks (adrenal suppression).
Paediatric dose
Dose: 1 mg/kg
Route: Oral
Frequency: Once daily in the morning
Max: 60mg/day
BNF for Children: IBD: 1–2mg/kg OD (max 60mg OD) for 4 weeks, then taper. Prescribe calcium + vitamin D supplementation. Source: BNF for Children 2024; ECCO Paediatric IBD Guidelines.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Reduced conversion to active form in severe hepatic impairment — may require increased dose or switch to prednisolone (which is the active form, unlike prednisone which requires hepatic conversion).
Paediatric weight-based calculator
BNF for Children: IBD: 1–2mg/kg OD (max 60mg OD) for 4 weeks, then taper. Prescribe calcium + vitamin D supplementation. Source: BNF for Children 2024; ECCO Paediatric IBD Guidelines.
Clinical pearls
- Bone protection: prescribe calcium 1000mg + vitamin D 800 IU/day from day 1 if steroid course expected >3 months. Add bisphosphonate (alendronate) if ≥7.5mg prednisolone for ≥3 months (NICE TA161).
- Steroid diabetes: check fasting glucose at baseline and after 2 weeks — afternoon glucose peak most significant. Refer to diabetes team if glucose >11mmol/L.
- Acute severe UC: Oxford criteria for predicting need for colectomy — >8 stools/day or CRP >45mg/L + 3–8 stools/day at 72h = 85% colectomy risk. Reassess at 72h.
- Steroid card: provide steroid emergency card for courses >3 weeks — patients must carry it for anaesthetic and surgical emergencies (adrenal crisis risk).
Contraindications
- Systemic infection without antimicrobial cover
- Live vaccine administration during systemic steroid use
- Cushing's syndrome (relative)
Side effects
- Hyperglycaemia (monitor glucose — new-onset steroid diabetes common)
- Osteoporosis (calcium + vitamin D supplementation required for >3 months use)
- Adrenal suppression (with courses >3 weeks at >7.5mg/day — taper slowly)
- Cushingoid features (moon face, central obesity, striae)
- Peptic ulceration (add PPI if concomitant NSAID or high risk)
- Mood disturbance, insomnia
- Increased infection susceptibility
- Hypertension, fluid retention
Interactions
- NSAIDs: additive GI ulceration risk — add PPI
- Live vaccines: contraindicated during systemic steroid therapy
- Rifampicin / carbamazepine / phenytoin: reduced prednisolone efficacy (CYP3A4 induction)
- Warfarin: variable effect on INR — monitor
- Hypoglycaemics: steroid-induced hyperglycaemia antagonises effect — increase monitoring
Monitoring
- Blood glucose (day 1 and 2 weeks — steroid diabetes)
- Blood pressure
- Bone density (DXA if course >3 months)
- Weight
- Intraocular pressure (prolonged use — steroid glaucoma)
- FBC (infection risk)
- Potassium (hypokalaemia risk)
Reference: BNFc; BNF 90; NICE NG130 IBD; NICE TA161 Bisphosphonates; BSG UC Guidelines 2019; Oxford Criteria (Travis et al, Gut 1996). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SIRS Criteria and Sepsis Definition · Sepsis
- Steroid Dose Equivalence · Medications
- Maddrey Discriminant Function (Alcoholic Hepatitis) · Alcoholic Liver Disease
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Maddrey's Discriminant Function for Alcoholic Hepatitis · Hepatology
- Lille Model for Alcoholic Hepatitis · Hepatology
Drugs
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021